Items

Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19) (2021-12)

B. Lakatos, J. Kowalska, S. Antoniak, D. Gokengin, J. Begovac, A. Vassilenko, p. wasilevski, l. fleischhans, D. Lakatos, R. Matulionyte, K. Kase, A. Papadopoulus, N. Rukhadze, A. Harxhi, S. Hofman, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, C. Oprea, Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19), HIV MEDICINE, Vol. 23, No. 1468-1293, pp. 1 - 8, Dec, 2021
The use of unproven drugs for COVID-19 treatment in people living with HIV. (2023-06)

J. Kowalska, B. Rozplochowski, A. Harxhi, L. Fleischhans, S. Antonjak, D. Gokengin, A. Vassilenko, K. Almla, A. Papadopoulus, R. Matulionyte, N. Rukhadze, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, A. Horban, The use of unproven drugs for COVID-19 treatment in people living with HIV., Jun, 2023
Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2022)

J. Kowalska, D. Bursa, D. Jilich, S. Antoniak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, L. Fleishhans, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, 2022
HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe (2023-11)

C. Oprea, S. Quirke, I. Lanache, D. Bursa, S. Antoniak, A. Vassilenko, N. Bogdanić, K. Aimla, R. Matulionyte, A. Harxhi, B. Lakatos, L. Fleischhans, N. Rukhadze, D. Sedlacek, G. Dragović-Lukić, A. Verhaz, N. Yancheva, O. Acet, K. Protopapas, J. Kowalska, HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe, HIV MEDICINE, Nov, 2023
The burden and epidemiology of community-acquired central nervous system infections: a multinational study (2017-04)

H. Erdem, A. Inan, E. Guven, S. Hargreaves, L. Larsen, G. Shehata, E. Pernicova, E. Khan, L. Bastakova, S. Namani, A. Harxhi, T. Roganović, B. Lakatos, S. Uysal, The burden and epidemiology of community-acquired central nervous system infections: a multinational study, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES, Vol. 36, No. 9, pp. 1595 - 1611, Apr, 2017
The application of 137Cs and 210Pbex methods in soil erosion research of Titel loess plateau, Vojvodina, Northern Serbia (2020)

Kristina S. Kalkan, Sofija Forkapić, Slobodan B. Marković, Kristina Bikit, Milivoj B. Gavrilov, Radislav Tošić, Dušan Mrđa, Robert Lakatoš, The application of 137Cs and 210Pbex methods in soil erosion research of Titel loess plateau, Vojvodina, Northern Serbia, Open Geosciences, Vol. 12, No. 1, pp. 11 - 24, 2020
The case series of 34 patients with COVID-19 diagnosed with HIV infection from Central and Eastern European Countries - Euroguidelines in Central and Eastern Europe Network Group data (2020-09)

K. Kase, A. Skrzat-Klapaczyńska, A. Vassilenko, A. Harxhi, B. Lakatos, G. Dragović-Lukić, D. Jilich, A. Verhaz, N. Yancheva, F. Dumitrescu, D. Jilih, L. Machala, A. Skrzat-Klapaczyńska, R. Matulionyte, The case series of 34 patients with COVID-19 diagnosed with HIV infection from Central and Eastern European Countries - Euroguidelines in Central and Eastern Europe Network Group data, Pulmonology research and respiratory care, pp. medRxiv - free on line, Sep, 2020
The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease – a report from Central and Eastern Europe (2020-12)

J. Kowalska, K. Kase, A. Vassilenko, A. Harxhi, B. Lakatos, G. Dragović-Lukić, A. Verhaz, N. Yancheva, F. Dumitrescu, D. Jilich, L. Machala, A. Skrzat-Klapaczyńska, R. Matulionyte, The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease – a report from Central and Eastern Europe, INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, pp. 1 - 11, Dec, 2020
The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group (2022-05)

J. Kowalska, C. Bienkowski, L. Fleishhans, S. Antoniak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Gokengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Jancheva, J. Begovac, A. Horban, The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group, Viruses Journal, Vol. 14, No. 5, pp. 1 - 12, May, 2022
The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group (2022-06)

A. Skrzat-Klapaczyńska, J. Kowalska, S. Antonyak, T. Balayan, J. Begovac, D. Bursa, G. Dragović-Lukić, D. Gokengin, L. Afonina, A. Harxhi, D. Jilich, K. Kase, A. Verhaz, B. Lakatos, M. Mardarescu, R. Matulionyte, A. Panteleev, A. Papadopoulus, L. Sojak, C. Oprea, J. Tomazic, A. Vassilenko, M. Vasyliev, A. Verhaz, N. Yancheva, O. Yurin, A. Horban, The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Vol. 19 (13), No. 19(13), pp. 1 - 9, Jun, 2022
Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network (2022-10)

B. Matlosz, A. Skrzat-Klapaczyńska, S. Antoniak, T. Balayan, J. Begovac, G. Dragović-Lukić, D. Gusey, Đ. Jevtović, D. Jilich, K. Aimla, B. Lakatos, R. Matulionyte, A. Panteleev, A. Papadopoulus, N. Rukhadze, M. Stevanović, D. Sedlacek, A. Vassilenko, A. Verhaz, N. Yancheva, O. Yurin, A. Horban, J. Kowalska, Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Vol. 19, pp. 1 - 12, Oct, 2022
Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023)

A. Kerstin, J. Kowalska, R. Matulionyte, V. Mulabdic, A. Vassilenko, N. Bolokadze, D. Jilich, S. Antoniak, C. Oprea, T. Balayan, A. Harxhi, A. Papadopoulus, B. Lakatos, M. Vasylyev, J. Begovac, N. Yancheva, A. Streinu-Cercel, A. Verhaz, D. Gokengin, G. Dragović-Lukić, L. Sojak, A. Skrzat-Klapaczyńska, Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group, EXPERT REVIEW OF VACCINES, Vol. 11, pp. 1 - 9, 2023
PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future (2023-01)

D. Gokengin, D. Bursa, A. Skrzat-Klapaczyńska, I. Alexiev, E. Arsikj, T. Balayan, J. Begovac, A. Cicic, G. Dragović-Lukić, A. Harxhi, K. Aimla, B. Lakatos, R. Matulionyte, V. Mulabdić, C. Oprea, A. Papadopoulus, N. Rukhadze, D. Sedlacek, L. Sojak, J. Tomazic, A. Vassilenko, M. Vasyliev, A. Verhaz, A. Verhaz, N. Yancheva, O. Yurin, J. Kowalska, PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future, Vaccines , Vol. 11, No. 1, pp. 1 - 12, Jan, 2023
Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023-05)

A. Kerstin, J. Kowalska, R. Matulionyte, V. Mulabdić, A. Vassilenko, N. Bolokadze, D. Jilich, S. Antoniak, C. Oprea, T. Balayan, A. Harxhi, A. Papadopoulus, B. Lakatos, M. Vasylyev, J. Begovac, N. Yancheva, A. Streinu-Cercel, D. Gokengin, A. Verhaz, G. Dragović-Lukić, Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group, Vaccines, Vol. 11(5), pp. 980 - 987, May, 2023
Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group (2022-07)

J. Kowalska, M. Vasyliev, A. Harxhi, L. Fleischhans, S. Antoniak, D. Gokengin, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, B. Lakatos, G. Dragović-Lukić, D. Jilich, A. Verhaz, A. Verhaz, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group, Jul, 2022
Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)

J. Kowalska, C. Bieńkowski, L. Fleischhans, S. Antonjak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Goengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, . Horban, Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group, Nov, 2022

Items

Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19) (2021-12)

The use of unproven drugs for COVID-19 treatment in people living with HIV. (2023-06)

Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2022)

HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe (2023-11)

The burden and epidemiology of community-acquired central nervous system infections: a multinational study (2017-04)

The application of 137Cs and 210Pbex methods in soil erosion research of Titel loess plateau, Vojvodina, Northern Serbia (2020)

The case series of 34 patients with COVID-19 diagnosed with HIV infection from Central and Eastern European Countries - Euroguidelines in Central and Eastern Europe Network Group data (2020-09)

The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease – a report from Central and Eastern Europe (2020-12)

The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group (2022-05)

The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group (2022-06)

Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network (2022-10)

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023)

PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future (2023-01)

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023-05)

Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group (2022-07)

Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)